Overview
Status
Active
Registry date
2008-05-14
Share capital
50 000,00 PLN
Registered address
ul. Przechlewska 59, 77-304 Rzeczenica, Poland
Electronic delivery address
AE:PL-98593-75645-ABAJF-36
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 5.53mMedianUSD 109.30kAverageUSD 2.05m
Net profit
This companyUSD 665.56kMedianUSD -146.00AverageUSD 68.27k
Operating costs
This companyUSD 4.70mMedianUSD 161.19kAverageUSD 1.90m
Assets
This companyUSD 1.32mMedianUSD 124.37kAverageUSD 1.41m
Industry
Bank accounts
Registered as a VAT taxpayer on 2008-08-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Hendrikus Antonius Van Boxtel — Management Board Member
Monika Kamila Danielska — Attorney-in-fact (joint)
Natasja Rompaey De Vaal — Attorney-in-fact (joint)
Josep Ribas Maynou — Management Board Member
Manner of representation
Both members of the management board jointly or a member of the management board jointly with a commercial proxy are authorised to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bioiberica S.A. | 250 | $6,753.11 | 50% |
Van Hessen Participations B.v. | 250 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Josep Ribas Maynou (63) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Hendrikus Joannes Antonius Van Boxtel (58) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | — | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-12-20 | Address change (Asnyka 2, 89-600, Chojnice → Ul. Przechlewska 59, 77-304, Rzeczenica) | |
| 2015-09-24 | PKD change (Removed: 21; Added: 21.10.Z) | |
| 2014-11-28 | Address change (Strzelecka 9, 89-600, Chojnice → Asnyka 2, 89-600, Chojnice) | |
| 2008-05-14 | Entered in the register |
FAQ
The main business activity of Biotee Polska focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on May 14, 2008.
The headquarters is located at: ul. Przechlewska 59, 77-304 Rzeczenica.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $12,656,591 in 2024, which is a decrease of 76.7% compared to 2023.
Yes, the company recorded a net profit of $1,145,463 in 2024, meaning the company decreased its profit by 55.9%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $11,036,825 in 2024, representing 99% of all operating expenses.
Last updated: 2026-04-15
